Nuvectis Pharma, Inc.

Biotechnology • Healthcare • Fort Lee, NJ, United States • NVCT (NCM)

Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology. Its lead product candidate is NXP800, a novel small molecule that is in Phase 1b clinical trial for the treatment of patients with platinum-resistant ARID1a-mutated ovarian carcinoma. The company is also developing NXP900, a small molecule drug candidate, which is in Phase 1a clinical trial that inhibits the proto-oncogene c-Src and YES1 kinases for treating solid tumors. The company was formerly known as Centry Pharma, Inc. and changed its name to Nuvectis Pharma, Inc. in July 2021. Nuvectis Pharma, Inc. was incorporated in 2020 and is based in Fort Lee, New Jersey.

201 614 3150 1 Bridge Plaza, Fort Lee, NJ 07024, United States

Stock Performance (90 Days)

Data through Dec 29, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Nuvectis Pharma, Inc.'s (NASDAQ:NVCT) market cap rose US$18m last week; retail investors who hold 44% profited and so did insiders - Yahoo Finance

Yahoo Finance • Dec 5

Nuvectis Pharma Announces the Initiation of the Phase 1b - GlobeNewswire

GlobeNewswire • Dec 17

Nuvectis Pharma stock rating reiterated at Buy by H.C. Wainwright - Investing.com

Investing.com • Dec 3

Precision Trading with Nuvectis Pharma Inc. (NVCT) Risk Zones - Stock Traders Daily

Stock Traders Daily • Dec 15

Nuvectis Pharma Stock (NVCT) Opinions on NXP900 Trial Results - Quiver Quantitative

Quiver Quantitative • Oct 29

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Nuvectis Pharma, Inc. had layoffs?

No layoff events have been recorded for Nuvectis Pharma, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Nuvectis Pharma, Inc. have?

Nuvectis Pharma, Inc. has approximately 13 employees.

What industry is Nuvectis Pharma, Inc. in?

Nuvectis Pharma, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Nuvectis Pharma, Inc. a publicly traded company?

Yes, Nuvectis Pharma, Inc. is publicly traded under the ticker symbol NVCT on the NCM. The company has a market capitalization of approximately $0.20 billion.

Where is Nuvectis Pharma, Inc. headquartered?

Nuvectis Pharma, Inc. is headquartered in Fort Lee, NJ, United States at 1 Bridge Plaza, Fort Lee, NJ 07024, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.